|

The CATALINA Study

RECRUITINGSponsored by Wim Janssens
Actively Recruiting
SponsorWim Janssens
Started2022-10-25
Est. completion2025-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05008081

Summary

The CATALINA study is a prospective cohort study embedded within CICERO (Collaboration In COPD ExaceRbatiOns, a European Respiratory Society supported Clinical Research Collaboration), designed to collect standardised, longitudinal clinical data and biological samples in 20 centres across Europe and beyond.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age 18 years and older
* Established diagnosis of COPD by medical doctor (based on clinical history OR pulmonary function test with an FEV1/FVC \< 0.7)
* Current hospitalization with suspicion of an acute exacerbation of COPD (AECOPD)
* Inclusion within 48 hours post hospital admission
* Voluntary written informed consent of the participant or his/her representative obtained prior to any study procedure

Exclusion Criteria:

* Patients unwilling or unable to comply with study procedures
* Patients not requiring treatment with systemic corticosteroids, antibiotics or both as a minimum therapy for the index AECOPD
* Patients with a confirmed positive test result for COVID19, or those highly suspected based on clinical examination

Conditions2

COPDChronic Obstructive Pulmonary Disease Exacerbation

Browse More Trials

COPD trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.